BD3937246
6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide1,1-Dioxide , 98%+(mixtureofisomers) , 2259-96-3
Synonym(s):
6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide 1,1-dioxide
CAS NO.:2259-96-3
Empirical Formula: C14H16ClN3O4S2
Molecular Weight: 389.88
MDL number: MFCD00210192
EINECS: 218-859-7
Pack Size | Price | Stock | Quantity |
25mg | RMB528.00 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 234° |
Density | 1.3781 (rough estimate) |
refractive index | 1.6100 (estimate) |
storage temp. | 2-8°C |
solubility | Soluble in DMSO (up to 35 mg/ml) or in Ethanol (up to 9 mg/ml) |
pka | pKa 9.1(30% EtOH) (Uncertain) |
form | White to off-white solid. |
color | Off-white |
λmax | 273nm(lit.) |
Merck | 14,2754 |
Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
EPA Substance Registry System | 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide (2259-96-3) |
Description and Uses
Cyclothiazide (2259-96-3) is a positive allosteric modulator of AMPA receptors acting at a site distinct from that of 2,3-benzodiazepines.1,2 Clinically useful diuretic and antihypertensive agent.3 Induces robust epileptiform activity, inducing seizures but without neuronal death.4,5 Can be used to produce a new animal model for epilepsy.5
Diuretic; antihypertensive. A subunit-specific inhibitor of GABAC receptors.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H335-H319-H315 |
Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 2 |
RTECS | DK9610000 |
HS Code | 2935904000 |
Hazardous Substances Data | 2259-96-3(Hazardous Substances Data) |
Toxicity | LD50 oral in rat: > 5gm/kg |